Personalizing Cancer Drugs
Personalizing Cancer Drugs market is segmented by players, region (country), by Type and by Appli ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Personalized Medicines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 PM Diagnostics 1.2.3 PM Therapeutics 1.2.4 Personalized Medical Care 1.2.5 Personalized Nutrition & Wellness 1.3 Market by Application 1.3.1 Global Personalized Medicines Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Dietary Care Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Personalized Medicines Market Perspective (2017-2028) 2.2 Personalized Medicines Growth Trends by Region 2.2.1 Personalized Medicines Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Personalized Medicines Historic Market Size by Region (2017-2022) 2.2.3 Personalized Medicines Forecasted Market Size by Region (2023-2028) 2.3 Personalized Medicines Market Dynamics 2.3.1 Personalized Medicines Industry Trends 2.3.2 Personalized Medicines Market Drivers 2.3.3 Personalized Medicines Market Challenges 2.3.4 Personalized Medicines Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Personalized Medicines Players by Revenue 3.1.1 Global Top Personalized Medicines Players by Revenue (2017-2022) 3.1.2 Global Personalized Medicines Revenue Market Share by Players (2017-2022) 3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Personalized Medicines Revenue 3.4 Global Personalized Medicines Market Concentration Ratio 3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2021 3.5 Personalized Medicines Key Players Head office and Area Served 3.6 Key Players Personalized Medicines Product Solution and Service 3.7 Date of Enter into Personalized Medicines Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Personalized Medicines Breakdown Data by Type 4.1 Global Personalized Medicines Historic Market Size by Type (2017-2022) 4.2 Global Personalized Medicines Forecasted Market Size by Type (2023-2028) 5 Personalized Medicines Breakdown Data by Application 5.1 Global Personalized Medicines Historic Market Size by Application (2017-2022) 5.2 Global Personalized Medicines Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Personalized Medicines Market Size (2017-2028) 6.2 North America Personalized Medicines Market Size by Country (2017-2022) 6.3 North America Personalized Medicines Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Personalized Medicines Market Size (2017-2028) 7.2 Europe Personalized Medicines Market Size by Country (2017-2022) 7.3 Europe Personalized Medicines Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Personalized Medicines Market Size (2017-2028) 8.2 Asia-Pacific Personalized Medicines Market Size by Country (2017-2022) 8.3 Asia-Pacific Personalized Medicines Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Personalized Medicines Market Size (2017-2028) 9.2 Latin America Personalized Medicines Market Size by Country (2017-2022) 9.3 Latin America Personalized Medicines Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Personalized Medicines Market Size (2017-2028) 10.2 Middle East & Africa Personalized Medicines Market Size by Country (2017-2022) 10.3 Middle East & Africa Personalized Medicines Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 3G Biotech 11.1.1 3G Biotech Company Detail 11.1.2 3G Biotech Business Overview 11.1.3 3G Biotech Personalized Medicines Introduction 11.1.4 3G Biotech Revenue in Personalized Medicines Business (2017-2022) 11.1.5 3G Biotech Recent Development 11.2 Quest Diagnostics 11.2.1 Quest Diagnostics Company Detail 11.2.2 Quest Diagnostics Business Overview 11.2.3 Quest Diagnostics Personalized Medicines Introduction 11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2017-2022) 11.2.5 Quest Diagnostics Recent Development 11.3 Laboratory Corporation of America 11.3.1 Laboratory Corporation of America Company Detail 11.3.2 Laboratory Corporation of America Business Overview 11.3.3 Laboratory Corporation of America Personalized Medicines Introduction 11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2017-2022) 11.3.5 Laboratory Corporation of America Recent Development 11.4 Abbott 11.4.1 Abbott Company Detail 11.4.2 Abbott Business Overview 11.4.3 Abbott Personalized Medicines Introduction 11.4.4 Abbott Revenue in Personalized Medicines Business (2017-2022) 11.4.5 Abbott Recent Development 11.5 Agendia NV 11.5.1 Agendia NV Company Detail 11.5.2 Agendia NV Business Overview 11.5.3 Agendia NV Personalized Medicines Introduction 11.5.4 Agendia NV Revenue in Personalized Medicines Business (2017-2022) 11.5.5 Agendia NV Recent Development 11.6 Asuragen Inc 11.6.1 Asuragen Inc Company Detail 11.6.2 Asuragen Inc Business Overview 11.6.3 Asuragen Inc Personalized Medicines Introduction 11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2017-2022) 11.6.5 Asuragen Inc Recent Development 11.7 Becton Dickinson 11.7.1 Becton Dickinson Company Detail 11.7.2 Becton Dickinson Business Overview 11.7.3 Becton Dickinson Personalized Medicines Introduction 11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2017-2022) 11.7.5 Becton Dickinson Recent Development 11.8 CardioDx Inc. 11.8.1 CardioDx Inc. Company Detail 11.8.2 CardioDx Inc. Business Overview 11.8.3 CardioDx Inc. Personalized Medicines Introduction 11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2017-2022) 11.8.5 CardioDx Inc. Recent Development 11.9 Foundation Medicine 11.9.1 Foundation Medicine Company Detail 11.9.2 Foundation Medicine Business Overview 11.9.3 Foundation Medicine Personalized Medicines Introduction 11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2017-2022) 11.9.5 Foundation Medicine Recent Development 11.10 Qiagen 11.10.1 Qiagen Company Detail 11.10.2 Qiagen Business Overview 11.10.3 Qiagen Personalized Medicines Introduction 11.10.4 Qiagen Revenue in Personalized Medicines Business (2017-2022) 11.10.5 Qiagen Recent Development 11.11 Siemens Healthcare 11.11.1 Siemens Healthcare Company Detail 11.11.2 Siemens Healthcare Business Overview 11.11.3 Siemens Healthcare Personalized Medicines Introduction 11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2017-2022) 11.11.5 Siemens Healthcare Recent Development 11.12 Amgen 11.12.1 Amgen Company Detail 11.12.2 Amgen Business Overview 11.12.3 Amgen Personalized Medicines Introduction 11.12.4 Amgen Revenue in Personalized Medicines Business (2017-2022) 11.12.5 Amgen Recent Development 11.13 Bristol-Myers Squibb 11.13.1 Bristol-Myers Squibb Company Detail 11.13.2 Bristol-Myers Squibb Business Overview 11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction 11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2017-2022) 11.13.5 Bristol-Myers Squibb Recent Development 11.14 GE Healthcare 11.14.1 GE Healthcare Company Detail 11.14.2 GE Healthcare Business Overview 11.14.3 GE Healthcare Personalized Medicines Introduction 11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2017-2022) 11.14.5 GE Healthcare Recent Development 11.15 Pfizer 11.15.1 Pfizer Company Detail 11.15.2 Pfizer Business Overview 11.15.3 Pfizer Personalized Medicines Introduction 11.15.4 Pfizer Revenue in Personalized Medicines Business (2017-2022) 11.15.5 Pfizer Recent Development 11.16 Sanofi 11.16.1 Sanofi Company Detail 11.16.2 Sanofi Business Overview 11.16.3 Sanofi Personalized Medicines Introduction 11.16.4 Sanofi Revenue in Personalized Medicines Business (2017-2022) 11.16.5 Sanofi Recent Development 11.17 23andMe 11.17.1 23andMe Company Detail 11.17.2 23andMe Business Overview 11.17.3 23andMe Personalized Medicines Introduction 11.17.4 23andMe Revenue in Personalized Medicines Business (2017-2022) 11.17.5 23andMe Recent Development 11.18 Illumina 11.18.1 Illumina Company Detail 11.18.2 Illumina Business Overview 11.18.3 Illumina Personalized Medicines Introduction 11.18.4 Illumina Revenue in Personalized Medicines Business (2017-2022) 11.18.5 Illumina Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Personalized Medicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of PM Diagnostics Table 3. Key Players of PM Therapeutics Table 4. Key Players of Personalized Medical Care Table 5. Key Players of Personalized Nutrition & Wellness Table 6. Global Personalized Medicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Personalized Medicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Personalized Medicines Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Personalized Medicines Market Share by Region (2017-2022) Table 10. Global Personalized Medicines Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Personalized Medicines Market Share by Region (2023-2028) Table 12. Personalized Medicines Market Trends Table 13. Personalized Medicines Market Drivers Table 14. Personalized Medicines Market Challenges Table 15. Personalized Medicines Market Restraints Table 16. Global Personalized Medicines Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Personalized Medicines Market Share by Players (2017-2022) Table 18. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2021) Table 19. Ranking of Global Top Personalized Medicines Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Personalized Medicines Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Personalized Medicines Product Solution and Service Table 23. Date of Enter into Personalized Medicines Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Personalized Medicines Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Personalized Medicines Revenue Market Share by Type (2017-2022) Table 27. Global Personalized Medicines Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Personalized Medicines Revenue Market Share by Type (2023-2028) Table 29. Global Personalized Medicines Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Personalized Medicines Revenue Market Share by Application (2017-2022) Table 31. Global Personalized Medicines Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Personalized Medicines Revenue Market Share by Application (2023-2028) Table 33. North America Personalized Medicines Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Personalized Medicines Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Personalized Medicines Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Personalized Medicines Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Personalized Medicines Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Personalized Medicines Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Personalized Medicines Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Personalized Medicines Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Personalized Medicines Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Personalized Medicines Market Size by Country (2023-2028) & (US$ Million) Table 43. 3G Biotech Company Detail Table 44. 3G Biotech Business Overview Table 45. 3G Biotech Personalized Medicines Product Table 46. 3G Biotech Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 47. 3G Biotech Recent Development Table 48. Quest Diagnostics Company Detail Table 49. Quest Diagnostics Business Overview Table 50. Quest Diagnostics Personalized Medicines Product Table 51. Quest Diagnostics Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 52. Quest Diagnostics Recent Development Table 53. Laboratory Corporation of America Company Detail Table 54. Laboratory Corporation of America Business Overview Table 55. Laboratory Corporation of America Personalized Medicines Product Table 56. Laboratory Corporation of America Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 57. Laboratory Corporation of America Recent Development Table 58. Abbott Company Detail Table 59. Abbott Business Overview Table 60. Abbott Personalized Medicines Product Table 61. Abbott Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 62. Abbott Recent Development Table 63. Agendia NV Company Detail Table 64. Agendia NV Business Overview Table 65. Agendia NV Personalized Medicines Product Table 66. Agendia NV Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 67. Agendia NV Recent Development Table 68. Asuragen Inc Company Detail Table 69. Asuragen Inc Business Overview Table 70. Asuragen Inc Personalized Medicines Product Table 71. Asuragen Inc Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 72. Asuragen Inc Recent Development Table 73. Becton Dickinson Company Detail Table 74. Becton Dickinson Business Overview Table 75. Becton Dickinson Personalized Medicines Product Table 76. Becton Dickinson Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 77. Becton Dickinson Recent Development Table 78. CardioDx Inc. Company Detail Table 79. CardioDx Inc. Business Overview Table 80. CardioDx Inc. Personalized Medicines Product Table 81. CardioDx Inc. Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 82. CardioDx Inc. Recent Development Table 83. Foundation Medicine Company Detail Table 84. Foundation Medicine Business Overview Table 85. Foundation Medicine Personalized Medicines Product Table 86. Foundation Medicine Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 87. Foundation Medicine Recent Development Table 88. Qiagen Company Detail Table 89. Qiagen Business Overview Table 90. Qiagen Personalized Medicines Product Table 91. Qiagen Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 92. Qiagen Recent Development Table 93. Siemens Healthcare Company Detail Table 94. Siemens Healthcare Business Overview Table 95. Siemens Healthcare Personalized MedicinesProduct Table 96. Siemens Healthcare Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 97. Siemens Healthcare Recent Development Table 98. Amgen Company Detail Table 99. Amgen Business Overview Table 100. Amgen Personalized MedicinesProduct Table 101. Amgen Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 102. Amgen Recent Development Table 103. Bristol-Myers Squibb Company Detail Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Personalized MedicinesProduct Table 106. Bristol-Myers Squibb Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 107. Bristol-Myers Squibb Recent Development Table 108. GE Healthcare Company Detail Table 109. GE Healthcare Business Overview Table 110. GE Healthcare Personalized MedicinesProduct Table 111. GE Healthcare Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 112. GE Healthcare Recent Development Table 113. Pfizer Company Detail Table 114. Pfizer Business Overview Table 115. Pfizer Personalized MedicinesProduct Table 116. Pfizer Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 117. Pfizer Recent Development Table 118. Sanofi Company Detail Table 119. Sanofi Business Overview Table 120. Sanofi Personalized MedicinesProduct Table 121. Sanofi Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 122. Sanofi Recent Development Table 123. 23andMe Company Detail Table 124. 23andMe Business Overview Table 125. 23andMe Personalized MedicinesProduct Table 126. 23andMe Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 127. 23andMe Recent Development Table 128. Illumina Company Detail Table 129. Illumina Business Overview Table 130. Illumina Personalized MedicinesProduct Table 131. Illumina Revenue in Personalized Medicines Business (2017-2022) & (US$ Million) Table 132. Illumina Recent Development Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Personalized Medicines Market Share by Type: 2021 VS 2028 Figure 2. PM Diagnostics Features Figure 3. PM Therapeutics Features Figure 4. Personalized Medical Care Features Figure 5. Personalized Nutrition & Wellness Features Figure 6. Global Personalized Medicines Market Share by Application in 2021 & 2028 Figure 7. Hospitals Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Dietary Care Centers Case Studies Figure 10. Others Case Studies Figure 11. Personalized Medicines Report Years Considered Figure 12. Global Personalized Medicines Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Personalized Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Personalized Medicines Market Share by Region: 2021 VS 2028 Figure 15. Global Personalized Medicines Market Share by Players in 2021 Figure 16. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Personalized Medicines Revenue in 2021 Figure 18. North America Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Personalized Medicines Market Share by Country (2017-2028) Figure 20. United States Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Personalized Medicines Market Share by Country (2017-2028) Figure 24. Germany Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Personalized Medicines Market Share by Region (2017-2028) Figure 32. China Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Personalized Medicines Market Share by Country (2017-2028) Figure 40. Mexico Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Personalized Medicines Market Share by Country (2017-2028) Figure 44. Turkey Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. 3G Biotech Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 47. Quest Diagnostics Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 48. Laboratory Corporation of America Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 49. Abbott Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 50. Agendia NV Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 51. Asuragen Inc Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 52. Becton Dickinson Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 53. CardioDx Inc. Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 54. Foundation Medicine Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 55. Qiagen Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 56. Siemens Healthcare Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 57. Amgen Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 59. GE Healthcare Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 60. Pfizer Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 61. Sanofi Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 62. 23andMe Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 63. Illumina Revenue Growth Rate in Personalized Medicines Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed
3G Biotech Quest Diagnostics Laboratory Corporation of America Abbott Agendia NV Asuragen Inc Becton Dickinson CardioDx Inc. Foundation Medicine Qiagen Siemens Healthcare Amgen Bristol-Myers Squibb GE Healthcare Pfizer Sanofi 23andMe Illumina
Personalizing Cancer Drugs market is segmented by players, region (country), by Type and by Appli ... Read More
Pest Control Products market is segmented by players, region (country), by Type and by Applicatio ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More